News Muncher - searching for cases

Coronavirus Updates: 85 Fresh Omicron Cases in Maharashtra Today; WHO Says Variant Leading to Tsunami of Infections

Maharashtra on Wednesday reported 85 new cases of the Omicron variant. Coronavirus cases surged across Australia on Wednesday as an outbreak of the omicron variant spread, with new infections in Sydney and surrounding parts of New South Wales state skyrocketing to more than 11,000, up from 6,000 a day earlier. On Wednesday, New South Wales Australia’s most populous state reported …

Cases

Following restricted emergency use recommendation for Covovax, Biological E’s jab Corbevax and anti-Covid pill Molnupiravir granted by an expert panel, the Drugs Controller General of India also granted approval for the above mentioned drugs. Coronavirus cases surged across Australia on Wednesday as an outbreak of the omicron variant spread, with new infections in Sydney and surrounding parts of New South …

These exemptions have been made in light of the huge vaccination requirements in India in the wake of the recent surge of COVID-19 cases and the need for increased availability of imported vaccines to meet national requirements India’s apex drug regulator has waived the requirement of testing every batch of foreign-made COVID-19 vaccines by the Central Drugs Laboratory, Kasauli and …

Zydus announces prices for its Covid drug Virafin approved by DCGI for use in moderate cases

Drug Firm Zydus Cadila has set the price of its medicine ‘Virafin' at Rs 11,995 per dose. After the DCGI's approval for use of this medicine in the treatment of moderate cases of Covid-19, the pharma giant has begun dispatching doses to its vendors. 'Virafin,' a single-use medication obtained emergency use clearance from the Drug Controller General of India, the …

In the last month, India went from reporting around 25,000+ Covid-19 cases to 1,85,000+ cases. In May 2020, the US Food and Drug Administration issued an emergency use authorisation for Remdesivir for the treatment of Covid-19 in adults and children hospitalised with severe disease. It may also help to conserve scarce health care resources, such as ventilators, during this pandemic.” …

COVID-19 vaccine dry run in all states on 2 Jan, SEC meet tomorrow; cases of UK strain rise to 25

India's COVID-19 tally surpasses 50 lakh with 90,123 new cases: AstraZeneca trials to resume

The Serum Institute of India, which had paused phase 2 and phase 3 trials of the Oxford University’s vaccine, received the go-ahead from the DCGI to resume the trials in India India’s coronavirus case count crossed 50 lakh on Wednesday with 90,123 new cases being reported in the 24 hours since 8 am on Tuesday. India records 10 lakh cases …

India sets global record with 95,735 COVID-19 cases in 24 hrs, tally crosses 44 lakh; SII pauses vaccine trials

Meanwhile, Delhi reported 4,308 fresh coronavirus cases on Thursday, the highest single-day spike so far, as a record 58,340 tests were conducted in the last 24 hours The tally of coronavirus cases in India crossed 44 lakh with a spike of 95,735 new cases on Thursday, the Union health ministry said. Delhi ICU beds to be increased The National Capital …

Drugs Controller General of India approved monoclonal antibody injection Itolizumab for limited use to treat moderate to severe cases of COVID-19. New Delhi: India’s drug regulator has approved Itolizumab, a drug used to cure skin ailment psoriasis for “restricted emergency use” to treat COVID-19 patients with moderate to severe acute respiratory distress, officials told PTI on Friday. Considering the unmet …

The drug has been granted approval by DCGI for the treatment of suspected or laboratory-confirmed cases of COVID-19 in adults and children, hospitalised with severe symptoms of the disease, the company said. New Delhi: Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19. Domestic pharma …